Ocugen (NASDAQ:OCGN) Shares Gap Down to $0.56

Ocugen (NASDAQ:OCGN) gapped down prior to trading on Tuesday . The stock had previously closed at $0.58, but opened at $0.56. Ocugen shares last traded at $0.41, with a volume of 5,873,600 shares traded.

Separately, ValuEngine upgraded shares of Ocugen from a “hold” rating to a “buy” rating in a report on Friday, November 1st.

Get Ocugen alerts:

The firm has a market capitalization of $8.95 million, a P/E ratio of -0.01 and a beta of 2.92.

In other Ocugen news, Director Howard C. Draft acquired 68,965 shares of the stock in a transaction dated Thursday, September 26th. The shares were purchased at an average price of $29.00 per share, for a total transaction of $1,999,985.00. Also, Director Junge Zhang acquired 31,078 shares of the stock in a transaction dated Monday, September 30th. The stock was acquired at an average price of $3.09 per share, for a total transaction of $96,031.02. Insiders bought a total of 209,043 shares of company stock worth $2,153,696 in the last quarter. Company insiders own 44.70% of the company’s stock.

Ocugen Company Profile (NASDAQ:OCGN)

Ocugen, Inc, a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing a pipeline of innovative therapies that address rare and underserved eye diseases. The company offers an ophthalmology portfolio that includes novel gene therapies, biologics, and small molecules, as well as targets a range of retinal and ocular surface diseases.

Featured Story: What is Depreciation?

Receive News & Ratings for Ocugen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ocugen and related companies with MarketBeat.com's FREE daily email newsletter.